Good potential just needs to demonstrate sales traction APAS...

Good potential just needs to demonstrate sales traction

APAS Clinical

• In addition to the US, Thermo Fisher have recently been appointed distributor for the EU market.

• In the latest ********* interview it was suggested further sale/s expected this calendar year. We’ll have to wait and see

APAS Pharma

• Recently received $1.7m development funding from AstraZeneca and Thermo

• Development expected end of this year and sales next year (given AstraZeneca are funding its development would expect they’ll be rolling out across their manufacturing sites - as suggested in that interview)

• In addition to AstraZeneca, APAS being placed with another pharma company

APAS pharma is a new capability - could be very fruitful, but we’ll have to wait and see.